P-362 Role of mitogen-activated protein kinase (MAPK) and AKT as predictive factors for response to ZD 1839 therapy in non-small cell lung cancer (NSCLC) patients

Federico Cappuzzo, Vanesa Gregorc, Laura Iombardo, Elisabetta Magrini, Alessandra Cancellieri, Carlo Terenzio Paties, Giovanni Luca Ceresoli, Stefania Bartolini, Eugenio Villa, Lucio Crino
  • Lung Cancer, August 2003, Elsevier
  • DOI: 10.1016/s0169-5002(03)92330-0

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication


The following have contributed to this page: Dr Federico Cappuzzo